Medios AG
ILM1.DE
$-0.02
Change (1 day)
$20.02
Year High
$14.87
Year Low
Categories
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Medios AG (ILM1.DE) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 145.77 M | -58,310,809 | 136.27 M | 643.52 M | 291.27 M |
| 2022 | 130.76 M | -66,629,177 | 138.4 M | 623.18 M | 270.51 M |
| 2021 | 104.62 M | -128,455,384 | 140.64 M | 567.12 M | 325.32 M |
| 2020 | 88.68 M | -608,081 | 56.38 M | 210.49 M | 147.48 M |
| 2019 | 52.2 M | -10,149,503 | 37.81 M | 126.13 M | 85.94 M |